Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · D14 in 2019 · Part D · DD4 Drug Safety and Accuracy of Drug Pricing

Statin Use in Persons with Diabetes (SUPD)

Drug PlanMedication AdherenceSource: Prescription Drug Events

What it measures
To lower their risk of developing heart disease, most people with diabetes should take cholesterol medication. This rating is based on the percent of plan members with diabetes who take the most effective cholesterol-lowering drugs. Plans can help make sure their members get these prescriptions filled.
How it's calculated
This measure is defined as the percent of Medicare Part D beneficiaries 40-75 years old who were dispensed at least two diabetes medication fills who received a statin medication fill during the measurement period. The percentage is calculated as the number of member-years of enrolled beneficiaries 40-75 years old who received a statin medication fill during the measurement period (numerator) divided by the number of member-years of enrolled beneficiaries 40-75 years old with at least two diabetes medication fills during the measurement period (denominator). Beneficiaries with an ESRD diagnosis or coverage dates, or enrolled in hospice are excluded. The SUPD measure is adapted from the measure concept that was developed and endorsed by the Pharmacy Quality Alliance (PQA). See the medication list for this measure. The SUPD measure is calculated using the National Drug Code (NDC) lists updated by the PQA. The complete NDC lists, including diagnosis codes, are posted along with these technical notes. NDCs with obsolete dates will be included in the measure calculation if the obsolete dates as reported by PQA are within the period of measurement (measurement year) or within six months prior to the beginning of the measurement year.
Data source
Prescription Drug Event (PDE) data The data for this measure come from Prescription Drug Event (PDE) data files submitted by drug plans to Medicare for dates of service from January 1, 2017- December 31, 2017, and processed by June 30, 2018. Only final action PDE claims are used to calculate the patient safety measures. PDE adjustments made post- reconciliation were not reflected in this measure. Additional data sources include the Common Medicare Environment (CME), the Medicare Enrollment Database (EDB), the Common Working File (CWF), and the Risk Adjustment Processing System (RAPS). • CME is used for enrollment information. • EDB is used for hospice enrollment and ESRD status (using the ESRD indicator). • CWF is used to identify exclusion diagnoses based on ICD-10-CM codes • RAPS is used for diagnosis information, RxHCC - Dialysis Status (most recent available Payment Year)
Measurement period
01/01/2017 – 12/31/2017
Better when
Higher
Weight
1 (Intermediate Outcome Measure)
Star assignment
Clustering
Case-mix adjusted
—
In improvement measure
No
Used in CAI
No
Exclusions
ShowA percentage is not calculated for contracts with 30 or fewer beneficiary member years (in the denominator).
Notes
Part D drugs do not include drugs or classes of drugs, or their medical uses, which may be excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, except for smoking cessation agents. As such, these drugs, which may be included in the medication or NDC lists, are excluded from CMS analyses. Also, the member-years of enrollment adjustment is made by CMS to account for partial enrollment within the benefit year. Enrollment is measured at the episode level, and inclusion in the measure is determined separately for each episode – i.e., to be included for a given episode, the beneficiary must meet the initial inclusion criteria for the measure during that episode. The measure is weighted based on the total number of member years for each episode in which the beneficiary meets the measure criteria. For instance, if a beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode, reenrolled for a three-month episode, and meets the measure criteria during each enrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + 3/12 = 6/12). When available, beneficiary death date from the CME is the end date of a beneficiary’s measurement period.
Disaster policy
Higher measure star (2018-2019) for contracts with 25% or more enrolled affected

From the 2019 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA-PD8384.5+1.5
3★MA-PD8789+2
4★MA-PD9091+1
5★MA-PD9495+1
2★PDP8182.5+1.5
3★PDP8383.5+0.5
4★PDP8585.5+0.5
5★PDP8788+1

2019 star distribution

Not rated: Plan too new to be measured (120); No data available (56); Not enough data available (14); Plan not required to report measure (11)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA-PD< 83 %>= 83 % to < 87 %>= 87 % to < 90 %>= 90 % to < 94 %>= 94 %
2027PDP< 81 %>= 81 % to < 83 %>= 83 % to < 85 %>= 85 % to < 87 %>= 87 %
2026MA-PD< 81 %>= 81 % to < 85 %>= 85 % to < 89 %>= 89 % to < 93 %>= 93 %
2026PDP< 82 %>= 82 % to < 83 %>= 83 % to < 84 %>= 84 % to < 86 %>= 86 %
2025MA-PD< 81 %>= 81 % to < 86 %>= 86 % to < 89 %>= 89 % to < 93 %>= 93 %
2025PDP< 80 %>= 80 % to < 83 %>= 83 % to < 85 %>= 85 % to < 87 %>= 87 %
2024MA-PD< 81 %>= 81 % to < 86 %>= 86 % to < 88 %>= 88 % to < 92 %>= 92 %
2024PDP< 81 %>= 81 % to < 83 %>= 83 % to < 85 %>= 85 % to < 87 %>= 87 %
2023MA-PD< 80 %>= 80 % to < 84 %>= 84 % to < 86 %>= 86 % to < 90 %>= 90 %
2023PDP< 80 %>= 80 % to < 82 %>= 82 % to < 84 %>= 84 % to < 86 %>= 86 %
2022MA-PD< 76 %>= 76 % to < 80 %>= 80 % to < 84 %>= 84 % to < 88 %>= 88 %
2022PDP< 77 %>= 77 % to < 79 %>= 79 % to < 82 %>= 82 % to < 84 %>= 84 %
2021MA-PD< 77 %>= 77 % to < 81 %>= 81 % to < 83 %>= 83 % to < 87 %>= 87 %
2021PDP< 74 %>= 74 % to < 79 %>= 79 % to < 82 %>= 82 % to < 85 %>= 85 %
2020MA-PD< 74%? 74% to < 78%? 78% to < 81%? 81% to < 83%? 83%
2020PDP< 76%? 76% to < 78%? 78% to < 79%? 79% to < 83%? 83%
2019MA-PD< 72%? 72% to < 76%? 76% to < 80%? 80% to < 83%? 83%
2019PDP< 73%? 73% to < 77%? 77% to < 79%? 79% to < 82%? 82%

Lowest-scoring contracts, 2019

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
H0062 WellcareCentene Corporation8,890651—150%
S0586 MVP Health CareMVP Health Care, Inc.235671—120%
H8067 Provider Partners Health PlansRifkin Managed Care Holding, LLC0661—140%
H3206 Presbyterian Insurance Company, Inc.Presbyterian Healthcare Services—671—130%
H9699 Arkansas Blue MedicareUSAble Mutual Insurance Company7,909681—121%
H2161 Upper Peninsula Health PlanDLP Marquette General Hospital, LLC—681—121%
H3170 Blue Cross and Blue Shield of NebraskaBlue Cross Blue Shield of Nebraska6,760681—121%
H1189 CHRISTUS Health AdvantageCHRISTUS Health8,875691—111%
H4754 PacificSource MedicarePacificSource2,527691—111%
H6743 ATRIO Health PlansATRIO Health Plans21,042691—111%
S2668 Farm Bureau Health PlansTennessee Rural Health Improvement Association—701—92%
H4213 Arkansas Blue MedicareUSAble Mutual Insurance Company2,258701—102%
H8604 The Health PlanThe Health Plan of West Virginia, Inc.7,183701—102%
H1304 Regence BlueShield of IdahoCambia Health Solutions, Inc.902701—102%
H3706 GlobalHealthMHH Healthcare, L.P.19,643701—102%
H3814 ATRIO Health PlansATRIO Health Plans1,997701—102%
H1099 Health First Health Plans, Inc.Health First Shared Services, Inc.37,197711—93%
H3755 CommunityCare Senior Health Plan (HMO)St Francis Health System & St John Health System37,967722—84%
H4198 Integris Health Partners+ (HMO)St Francis Health System & St John Health System—722—84%
H1350 Blue Cross of IdahoGemstone Holdings, Inc.32,406722—84%
H3251 Blue Cross and Blue Shield of New MexicoHealth Care Service Corporation19,880722—84%
H4005 Triple-S AdvantageGuidewell Mutual Holding Corporation6,490722—84%
H8266 Constellation Health, Llc.Constellation Health, LLC.—722—84%
H4922 AgeWell New YorkParkerCare New York, LLC—722—84%
S2874 HumanaHumana Inc.—711—84%

History

Star yearCodeNameMeasuredWeightSource
2027D11Statin Use in Persons with Diabetes (SUPD)01/01/2025 – 12/31/20251Prescription Drug Events
2026D12Statin Use in Persons with Diabetes (SUPD)01/01/2024 – 12/31/20241Prescription Drug Events
2025D12Statin Use in Persons with Diabetes (SUPD)01/01/2023 – 12/31/20231Prescription Drug Events
2024D12Statin Use in Persons with Diabetes (SUPD)01/01/2022 – 12/31/20221Prescription Drug Events
2023D12Statin Use in Persons with Diabetes (SUPD)01/01/2021 – 12/31/20211Prescription Drug Events
2022D12Statin Use in Persons with Diabetes (SUPD)01/01/2020 – 12/31/20203Prescription Drug Events
2021D14Statin Use in Persons with Diabetes (SUPD)01/01/2019 – 12/31/20193Prescription Drug Events
2020D14Statin Use in Persons with Diabetes (SUPD)01/01/2018 – 12/31/20181Prescription Drug Events
2019D14Statin Use in Persons with Diabetes (SUPD)01/01/2017 – 12/31/20171Prescription Drug Events